Medically Reviewed By

Dr. Ian Strand, DO, FAAMM

Jul 1, 2026 Weight Loss GLP-1

GLP-1 Side Effects: What to Expect with Semaglutide and Tirzepatide

GLP-1 medications have become a common part of medical weight management, and one of the first questions people ask is a fair one: what is this going to feel like? The honest answer is that side effects are common, mostly digestive, and for most people manageable, but they are worth understanding before you start so nothing comes as a surprise.

Below is a plain-language look at what tends to happen, why, how long it usually lasts, and the kinds of things that may help. None of this replaces a conversation with the clinician managing your care.

The Most Common Side Effects

Across the large trials of semaglutide and tirzepatide, the side effects reported most often were gastrointestinal:

In the SURMOUNT-1 trial of tirzepatide and the STEP-1 trial of semaglutide, nausea was among the most frequently reported effects, and the great majority of digestive symptoms were described as mild to moderate. These were separate trials in different groups of people, so the exact percentages are not directly comparable, but the overall pattern was similar.

Why They Happen, and When

These medications slow how quickly the stomach empties and act on the body's appetite signals. That is a meaningful part of how they support weight management, and the digestive side effects come from the same mechanism. In other words, the thing causing the occasional queasiness is related to the thing helping with appetite.

Timing-wise, symptoms tend to be most noticeable in the first few weeks and after each step up in dose, then often settle as the body adapts. A 2025 analysis of the SURMOUNT tirzepatide trials described the digestive effects as generally transient and mild to moderate, most prominent during dose escalation. This is the reasoning behind starting low and increasing the dose gradually under a clinician's guidance.

Approaches That May Help

These are general habits that many people find helpful and that clinicians commonly discuss. They are not a treatment plan, and the right adjustments depend on you and the clinician managing your care.

• Eating smaller portions and stopping when comfortably full rather than stuffed.
• Eating slowly and giving fullness signals time to catch up.
• Going easy on very rich, greasy, or heavy meals, which some people find harder to tolerate early on.
• Staying hydrated, especially if appetite is low.
• Letting your clinician know early if symptoms are tough, since the dose schedule can often be adjusted.

One reassuring note from the trial data: only a small minority of participants stopped treatment because of digestive side effects, and analyses suggested the weight change was driven mostly by the medication's metabolic effects rather than by the side effects themselves. So feeling queasy is not a requirement for the medication to do its job.

Less Common, More Serious Effects

Beyond the digestive symptoms, the product labeling for these medications notes less common but more serious considerations, including a warning related to thyroid tumors observed in animal studies, and cautions around conditions such as pancreatitis and gallbladder disease. These are not reasons to panic, but they are reasons these medications are prescribed and monitored rather than bought casually. A clinician reviews your personal and family history before starting, watches how you respond, and is the right person to call if anything feels severe or out of the ordinary.

Frequently Asked Questions